Cancer Research Annual Meeting 2010 Protein Translation and Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Casanova, M. L.
Right arrow Articles by Jorcano, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Casanova, M. L.
Right arrow Articles by Jorcano, J. L.
[Cancer Research 62, 3402-3407, June 15, 2002]
© 2002 American Association for Cancer Research

Carcinogenesis

A Critical Role for ras-mediated, Epidermal Growth Factor Receptor-dependent Angiogenesis in Mouse Skin Carcinogenesis1

M. Llanos Casanova, Fernando Larcher, Benito Casanova, Rodolfo Murillas, M. Jesús Fernández-Aceñero, Concepción Villanueva, Jesús Martínez-Palacio, Axel Ullrich, Claudio J. Conti and Jose Luis Jorcano2

Project on Cell and Molecular Biology and Gene Therapy, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, 28040 Madrid, Spain [M. L. C., F. L., J. M-P., J. L. J.]; GENOTEK, 08206 Barcelona, Spain [B. C.]; National Cancer Institute, NIH, Bethesda, Maryland 20892 [R. M.]; Hospital General de Móstoles, 28935 Madrid, Spain [M. J. F-A., C. V.]; Max-Planck-Institute of Biochemistry, 82152 Martinsried, Germany [A. U.]; and The University of Texas M. D. Anderson Cancer Center Science Park, Smithville, Texas 78957 [C. J. C.]

Epidermal growth factor receptor (EGFR) plays a critical role in epidermal biology.Abnormal EGFR function has been described in epithelial tumors including those induced by two-stage chemical carcinogenesis in mouse skin. A large body of evidence indicates that in this model, activation of Ha-ras is the critical event in papilloma formation, a process that involves epidermal proliferation and stroma remodeling, which includes angiogenesis. This study reports that activated Ha-ras results in a dramatic induction of EGFR in epidermal tumor cells and provides experimental evidence that EGFR signaling is responsible for Ha-ras-dependent vascular endothelial growth factor (VEGF) induction, as well as for the repression of other angiogenic factors such as angiopoietin 1. The pivotal role of functional EGFR in throwing the angiogenic switch necessary for tumor growth was confirmed by s.c. injection of immunodeficient mice with epidermal tumor cells carrying a dominant negative (dn) EGFR and by in vivo chemical skin carcinogenesis assays in transgenic mice expressing the same dn EGFR form in the epidermis. Immunohistochemical analysis of the tumors obtained by both ex vivo and in vivo approaches showed that dn EGFR expression abolished the changes in blood vessels that occurred during tumor progression. A strong reduction of VEGF expression in dn EGFR tumors appears to be the key event responsible for angiogenesis and tumor growth suppression. The apoptotic rate was increased, and Akt activity was decreased, suggesting that impaired nutrient and oxygen supply might contribute to diminished cell survival in dn EGFR tumors. Support for this mechanism is provided by the fact that the ectopic expression of VEGF in dn EGFR-expressing tumor cell lines restored tumor growth capacity. Although ras activation might suffice for epidermal transformation and the stroma-remodeling events of tumor induction, such effects may not be operative without a functional upstream EGFR. It is tempting to speculate that EGFR family members may function as angiogenic regulators in other epithelial tumors such as those of the colon, breast, and prostate, reinforcing their value as targets for therapeutic intervention.




This article has been cited by other articles:


Home page
 Cancer Res.Home page
A. M. Bode, Y.-Y. Cho, D. Zheng, F. Zhu, M. E. Ericson, W.-Y. Ma, K. Yao, and Z. Dong
Transient Receptor Potential Type Vanilloid 1 Suppresses Skin Carcinogenesis
Cancer Res., February 1, 2009; 69(3): 905 - 913.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
K. M. Ansari, J. E. Rundhaug, and S. M. Fischer
Multiple Signaling Pathways Are Responsible for Prostaglandin E2-Induced Murine Keratinocyte Proliferation
Mol. Cancer Res., June 1, 2008; 6(6): 1003 - 1016.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
P. Lito, B. D. Mets, S. Kleff, S. O'Reilly, V. M. Maher, and J. J. McCormick
Evidence That Sprouty 2 Is Necessary for Sarcoma Formation by H-Ras Oncogene-transformed Human Fibroblasts
J. Biol. Chem., January 25, 2008; 283(4): 2002 - 2009.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
S. V. Sharma and J. Settleman
Oncogene addiction: setting the stage for molecularly targeted cancer therapy
Genes & Dev., December 15, 2007; 21(24): 3214 - 3231.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
J. Lu, O. Rho, E. Wilker, L. Beltran, and J. DiGiovanni
Activation of Epidermal Akt by Diverse Mouse Skin Tumor Promoters
Mol. Cancer Res., December 1, 2007; 5(12): 1342 - 1352.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. J. Gerdes, M. Myakishev, N. A. Frost, V. Rishi, J. Moitra, A. Acharya, M. R. Levy, S.-w. Park, A. Glick, S. H. Yuspa, et al.
Activator protein-1 activity regulates epithelial tumor cell identity.
Cancer Res., August 1, 2006; 66(15): 7578 - 7588.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
N. M. Kogan, C. Blazquez, L. Alvarez, R. Gallily, M. Schlesinger, M. Guzman, and R. Mechoulam
A Cannabinoid Quinone Inhibits Angiogenesis by Targeting Vascular Endothelial Cells
Mol. Pharmacol., July 1, 2006; 70(1): 51 - 59.
[Abstract] [Full Text] [PDF]

Home page
 Integr Cancer TherHome page
D. R. Yance Jr and S. M. Sagar
Targeting Angiogenesis With Integrative Cancer Therapies
Integr Cancer Ther, March 1, 2006; 5(1): 9 - 29.
[Abstract] [PDF]

Home page
 Cancer Res.Home page
D. Stevenson, C. Charalambous, and J. B. Wilson
Epstein-Barr Virus Latent Membrane Protein 1 (CAO) Up-regulates VEGF and TGF{alpha} Concomitant with Hyperlasia, with Subsequent Up-regulation of p16 and MMP9
Cancer Res., October 1, 2005; 65(19): 8826 - 8835.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
D. J. Hicklin and L. M. Ellis
Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis
J. Clin. Oncol., February 10, 2005; 23(5): 1011 - 1027.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C. Blazquez, L. Gonzalez-Feria, L. Alvarez, A. Haro, M. L. Casanova, and M. Guzman
Cannabinoids Inhibit the Vascular Endothelial Growth Factor Pathway in Gliomas
Cancer Res., August 15, 2004; 64(16): 5617 - 5623.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
C. Segrelles, S. Ruiz, M. Santos, J. Martinez-Palacio, M. F. Lara, and J. M. Paramio
Akt mediates an angiogenic switch in transformed keratinocytes
Carcinogenesis, July 1, 2004; 25(7): 1137 - 1147.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. S. Chan, S. Carbajal, K. Kiguchi, J. Clifford, S. Sano, and J. DiGiovanni
Epidermal Growth Factor Receptor-Mediated Activation of Stat3 during Multistage Skin Carcinogenesis
Cancer Res., April 1, 2004; 64(7): 2382 - 2389.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
C. J. Conti
Vascular Endothelial Growth Factor: Regulation in the Mouse Skin Carcinogenesis Model and Use in Antiangiogenesis Cancer Therapy
Oncologist, August 1, 2002; 7(90003): 4 - 11.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.